Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase

被引:48
|
作者
Liu, J
Chakraborty, C
Graham, CH
Barbin, YP
Dixon, SJ
Lala, PK
机构
[1] Univ Western Ontario, Fac Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada
[2] Univ Western Ontario, Dept Pathol, London, ON N6A 5C1, Canada
[3] Univ Western Ontario, Dept Physiol, London, ON N6A 5C1, Canada
[4] Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada
关键词
urokinase-type plasminogen activator; urokinase-type plasminogen activator receptors; migration; extravillous trophoblast; intracellular calcium; phosphatidylinositol; 3-kinase; phospholipase C; mitogen-activated protein kinase;
D O I
10.1016/S0014-4827(03)00089-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The serine protease urokinase-type plasminogen activator (uPA) promotes matrix degradation by many cell types, including the invasive extravillous trophoblast (EVT) of the human placenta. The noncatalytic amino-terminal end of uPA binds to uPA receptors (uPARs) expressed by these cells. A highly polarized expression of uPAR-bound uPA at the migration front of EVT cells in situ suggests a functional role of uPA:uPAR interaction in EVT cell migration. The present study examined whether uPA stimulates EVT cell migration, independent of proteolytic function, and investigated some of the signaling pathways involved. Using in vitro-propagated EVT cells in Transwell migration assays, both uPA and its noncatalytic amino-terminal fragment (ATF) were shown to stimulate migration through multiporous polycarbonate (pore size 8 mum) membranes. A uPAR-blocking antibody inhibited basal and ATF-stimulated migration. Migration was found to be stimulated by hypoxic conditions, which upregulates uPAR expression; this stimulation was abrogated with the uPAR-blocking antibody, indicating the role of endogenous uPA in EVT cell migration. Spectrofluorometric measurement of cytosolic calcium in cells treated with uPA and ATF demonstrated a rapid rise in [Ca2+](i), which was prevented by pretreatment of cells with thapsigargin, indicating a release from intracellular stores. Both basal and ATF-mediated migratory responses were suppressed in the presence of selective pharmacological inhibitors LY294002, U73122, and U0126, implicating the respective roles of phosphatidinylinositol 3-kinase (PI 3-K), phospholipase C (PLC), and MEK1/2 in basal and ATF-stimulated migratory capacity. Taken together, these results demonstrate that uPA:uPAR interaction stimulates EVT cell migration, independent of uPA enzymatic activity, using the mitogen-activated protein kinase pathway and calcium signaling events including the participation of PI 3-K and PLC. These findings are relevant to clinical conditions of aberrant trophoblast migration, including spontaneous abortion, preeclampsia, and choriocarcinoma. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:138 / 151
页数:14
相关论文
共 50 条
  • [41] Phosphatidylinositol 3-kinase is required for the regulation of hepatitis B surface antigen production and mitogen-activated protein kinase activation by insulin but not by TPA
    Lin, YL
    Chou, CK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (01) : 172 - 175
  • [42] Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells
    Edwards, LA
    Verreault, M
    Thiessen, B
    Dragowska, WH
    Hu, YP
    Yeung, JHF
    Dedhar, S
    Bally, MB
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (03) : 645 - 654
  • [43] Phosphatidylinositol 3-OH kinase activity is not required for activation of mitogen-activated protein kinase by cytokines
    Scheid, MP
    Duronio, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) : 18134 - 18139
  • [44] In cultured human vascular smooth muscle cells homocysteine activates both mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways: involvement of NMDA receptor
    Doronzo, G.
    Russo, I.
    Del Mese, P.
    Viretto, M.
    Mattiello, L.
    Trovati, M.
    Anfossi, G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 21 - 21
  • [45] Semaphorin 3F antagonizes neurotrophin-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase signaling: A mechanism for growth cone collapse
    Atwal, JK
    Singh, KK
    Tessier-Lavigne, M
    Miller, FD
    Kaplan, DR
    JOURNAL OF NEUROSCIENCE, 2003, 23 (20): : 7602 - 7609
  • [46] Role of crosstalk between phosphatidylinositol 3-kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase pathways in artery-vein specification
    Hong, Charles C.
    Kume, Tsutomu
    Peterson, Randall T.
    CIRCULATION RESEARCH, 2008, 103 (06) : 573 - 579
  • [47] Role of phosphoinositide 3-kinase in activation of Ras and mitogen-activated protein kinase by epidermal growth factor
    Wennström, S
    Downward, J
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (06) : 4279 - 4288
  • [48] Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis
    Lobenhofer, EK
    Huper, G
    Iglehart, JD
    Marks, JR
    CELL GROWTH & DIFFERENTIATION, 2000, 11 (02): : 99 - 110
  • [49] Dual inhibition of allosteric mitogen-activated protein kinase (MEK) and phosphatidylinositol 3-kinase (PI3K) oncogenic targets with a bifunctional inhibitor
    Van Dort, Marcian E.
    Galban, Stefanie
    Wang, Hanxiao
    Sebolt-Leopold, Judith
    Whitehead, Christopher
    Hong, Hao
    Rehemtulla, Alnawaz
    Ross, Brian D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (07) : 1386 - 1394
  • [50] Amphiregulin regulates odontogenic differentiation of dental pulp stem cells by activation of mitogen-activated protein kinase and the phosphatidylinositol 3-kinase signaling pathways
    Junqing Li
    Zhihua Wang
    Juan Wang
    Qian Guo
    Yi Fu
    Zihan Dai
    Minghao Wang
    Yu Bai
    Xin Liu
    Paul R. Cooper
    Jiayuan Wu
    Wenxi He
    Stem Cell Research & Therapy, 13